Insider trade

CEO sold ~$284K of UNH shares in the open market

Traded Apr 23, 2026 · Filed Apr 27, 2026

UnitedHealthUNH

~$284K
Reported value · 800 sh @ $355.00: 18K
Holds after · shares reported: +3.0%
stock since the trade · S&P 500 +7.8%, $354.56 → $365.20 on Oct 1

Why it stands out

The boss of UnitedHealth sold $284K of UnitedHealth shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Apr 23, 2026
Reporting period: Not applicable
Filed with the SEC: Apr 27, 2026

CEO$100K–$500K

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$284,000

Shares × reported transaction price

Timing vs results

2 days after results of Apr 21, 2026, 84 days before results of Jul 16, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $354.56 on Apr 23, 2026, 49% above its 52-week low and 16% below its high, after a 24% rise over the previous 30 trading days

52-week range $237.77 (Aug 1, 2025) to $424.25 (Apr 24, 2025), 63% of the way up, from 251 adjusted closes. 30 trading days earlier: $285.25 on Mar 11, 2026. Describes the past only, not a forecast

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Securities lawsuit open at the trade date

A securities lawsuit naming the company as a defendant was filed on Mar 20, 2026 in the U.S. District Court, District of Columbia. A filing is an allegation, not a finding.

2 such cases were open. FONDS DES MISSIONS v. UNITEDHEALTH GROUP INCORPORATED, docket 1:26-cv-00970, via CourtListener (court records). Nature of suit 850, company named as first defendant